METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.

Chen X, Xu M, Xu X, Zeng K, Liu X, Pan B, Li C, Sun L, Qin J, Xu T, He B, Pan Y, Sun H, Wang S. · 2020

Read METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. by Chen X, Xu M, Xu X, Zeng K, Liu X, Pan B, Li C, Sun L, Qin J, Xu T, He B, Pan Y, Sun H, Wang S. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7298962.txt.

Description

Chen and co-authors show that an RNA-modifying enzyme, METTL14, restrains the spread of colorectal cancer. Their study appeared in Molecular Cancer. Distant metastasis is the main cause of death in this cancer. METTL14 places the m6A mark on RNA and was significantly reduced in colorectal tumor tissue, with lower levels tied to poorer survival.

Statistical analysis marked METTL14 as an independent prognostic factor. Its own gene is silenced by another enzyme that strips a chemical mark from its promoter. Restoring METTL14 curbed cancer cell migration, invasion, and metastasis in laboratory and animal tests. Its target is SOX4, a gene that promotes spread: marking SOX4 RNA for control keeps it in check, and knocking down METTL14 removes that protection. The work links RNA modification to a concrete brake on metastasis.

Catalog record

CREATORChen X, Xu M, Xu X, Zeng K, Liu X, Pan B, Li C, Sun L, Qin J, Xu T, He B, Pan Y, Sun H, Wang S.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7298962

Browse the full library · About the Tower of Babel